Reducing obesity requires an elevation of energy expenditure and/or a suppression of food intake. Here we show that enhancing hepatic glycolysis reduces body weight and adiposity in obese mice. Overexpression of glucokinase or 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase is used to increase hepatic glycolysis. Either of the two treatments produces similar increases in rates of fatty acid oxidation in extrahepatic tissues, i.e., skeletal muscle, leading to an elevation of energy expenditure. However, only 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase overexpression causes a suppression of food intake and a decrease in hypothalamic neuropeptide Y expression, contributing to a more pronounced reduction of body weight with this treatment. Furthermore, the two treatments cause differential lipid profiles due to opposite effects on hepatic lipogenesis, associated with distinct phosphorylation states of carbohydrate response element binding protein and AMP-activated protein kinase. The step at which hepatic glycolysis is enhanced dramatically influences overall whole-body energy balance and lipid profiles.
Introduction
, or mice transgenic-expressing fibroblast growth factor-19 (FGF19) (Tomlinson et al., 2002) , fatty acid oxidation Obesity is highly associated with type 2 diabetes and causes is increased and whole-body energy expenditure is elevated. or exacerbates many health problems (Reaven, 1995) . The Consequently, fat mass and body weight are reduced or the mechanism for the pathogenesis of obesity remains unclear development of obesity is prevented. In these studies, reducbut in general terms is due to a loss of balance between energy tion of obesity involves a number of tissues, including liver, intake (feeding) and energy expenditure (Spiegelman and Flier, muscle, and brown adipose tissue, which cooperatively regu-2001). Thus, obesity develops when energy intake chronically late whole-body fuel utilization. However, the relative role of exceeds total body energy expenditure. Dysregulation of enindividual tissues in the determination of whole-body energy ergy expenditure, at least in part, is attributable to impaired expenditure is not well-defined. In addition, the above studies glucose and lipid metabolism. Notably, hyperinsulinemia, in demonstrate that elevating fatty acid oxidation can improve combination with hyperglycemia, inhibits fatty acid oxidation glucose homeostasis. How enhancing glucose utilization afin many tissues (Bavenholm et al., 2000; Chien et al., 2000;  fects lipid metabolism in terms of regulation of energy balance Rasmussen et al., 2002; Sidossis and Wolfe, 1996) . As a result, in obesity is not clear. Another approach for reduction of obelipogenesis is favored over fatty acid oxidation (Ruderman et sity is to suppress food intake. This is exemplified by peripheral al., 2003), leading to an increase in fat accumulation and a deadministration of glucagon-like peptide-1 (GLP-1) derivative, crease in energy expenditure. Food intake, as the other com-NN2211, which reduces food intake and body weight in obese ponent of energy balance, is controlled by the central nervous rats (Larsen et al., 2001 ). Since GLP-1 acts through binding to system (CNS), where the hypothalamus plays the most impor-
GLP-1 receptor in the CNS (Baggio et al., 2004) , this study tant role (Havel, 2001; Spiegelman and Flier, 2001) . In hypothalsuggests that effects on the CNS are associated with a reducamus, the arcuate nucleus (ARC) contains neurons expressing tion of obesity through suppression of food intake. neuropeptide Y (NPY) and agouti-related protein (AgRP), which Since insulin, in combination with glucose, is a major signal increase food intake, and neurons expressing pro-opiomelanothat regulates peripheral fatty acid oxidation (Bavenholm et al., cortin (POMC) and cocaine-amphetamine-related transcript Chien et al., 2000; Rasmussen et al., 2002 ; Sidossis and (CART), which suppress food intake (Friedman, 2004) . In geWolfe, 1996), we hypothesized that lowering plasma insulin netic obese mice, hypothalamic NPY and/or AgRP mRNAs are levels should be able to elevate energy expenditure and reduce elevated (Ollmann et al., 1997; Wilding et al., 1993) . These obesity. Lowering plasma insulin levels can be achieved by reducing plasma glucose levels via suppression of hepatic glucose changes are likely associated with increased food consumption (Williams et al., 2000) . production (HGP). In the liver, glucokinase (GK) and 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (6PFK2/FBP2) are One approach to reduce obesity is to elevate energy expenditure. In mice lacking acetyl-CoA carboxylase 2 (ACC2) (Abuthe two crucial enzymes that control glycolytic flux (Nordlie et al., 1999; Wu et al., 2005) . GK catalyzes glucose phosphorylaElheiga et al., 2001), stearoyl-CoA desaturase-1 (SCD1) (Cohen Obese KK/H1J mice were treated with adenovirus (Ad-GFP, Ad-GK, or Ad-Bif-BPD) on day 0 and followed for 7 days. A) Hepatic overexpression of GK or 6PFK2/FBP2. In (B), (C), and (D), data are means ± SE, n = 4-6. **p < 0.01 or ***p < 0.001 versus Ad-GFP. B) Glycolysis. C) Basal and insulin-suppressed hepatic glucose production (HGP). D) Basal and insulin-stimulated whole-body glucose disposal (Rd).
tion as the first step of glucose metabolism, whereas 6PFK2/ occurred predominantly in the liver. This view was substan-FBP2 (dephosphorylated hepatic isoform) elevates fructosetiated by the exclusive hepatic localization, in vivo, of green 2,6-bisphosphate (F26P 2 ) to activate 6-phosphofructo-1-kinase fluorescent protein (GFP) in the Ad-GFP-treated mice in the (6PFK1) and promotes the step in glycolysis from fructose-6-present study (data not shown). Upon enhancing hepatic glyphosphate (F6P) to fructose-1,6-bisphosphate (F16P 2 ). Thus, colysis, both basal and insulin-suppressed HGP were dewe chose to overexpress GK or 6PFK2/FBP2 in the liver of creased in Ad-GK-or Ad-Bif-BPD-treated mice compared to obese mice to explore the role of liver, particularly hepatic glythose of Ad-GFP-treated mice ( Figure 1C ). Whole-body glucolysis, in the regulation of energy balance and obesity. In the cose disposal, calculated as the rate of glucose disappearance course of these studies, we found dramatically different out-(Rd), was decreased under the basal condition but increased comes depending on the site of glycolysis targeted.
under the hyperinsulinemic condition in Ad-GK-or Ad-Bif-BPD-treated mice ( Figure 1D ). Results
Reduction of body weight and adiposity Enhancement of hepatic glycolysis
Upon enhancing hepatic glycolysis, Ad-GK-or Ad-Bif-BPDIn order to enhance hepatic glycolysis, Ad-GK or Ad-Bif-BPD treated KK/H1J mice showed reductions in body weight and were introduced into obese KK/H1J mice, a polygenic model adiposity, compared to Ad-GFP-treated mice (Figures 2A and of obesity and type 2 diabetes (Bouchard et al., 2002; Igel et 2B) . Interestingly, Ad-Bif-BPD treatment produced much greater al., 1998; Koishi et al., 2002; Nagase et al., 1996) . Seven days effects on reducing body weight than Ad-GK treatment. Since after viral infusion, overexpression of either enzyme in livers of Ad-Bif-BPD treatment also suppressed food intake (see bethe treated mice was evident ( Figure 1A ). These manipulations low), a group of Ad-GFP-treated mice were pair fed (Ad-GFPcaused a similar increase in hepatic glycolysis, which was evi-PF) with mice treated with Ad-Bif-BPD. Food restriction caused denced by elevated levels of hepatic lactate (Table 1) . In addia reduction of body weight and adiposity, but this effect was tion, whole-body glycolysis, measured during euglycemic/ not as pronounced as that caused by Ad-Bif-BPD treatment hyperinsulinemic clamp, was also increased similarly in Ad- (Figures 2A and 2B) . Hence, the suppression of food intake GK-or Ad-Bif-BPD-treated mice ( Figure 1B Obese KK/H1J mice were treated with adenoviruses on day 0 and followed for 7 days. Hepatic metabolites were measured from frozen tissues that were collected on day 7 after 5 hr RQ experiment (5 hr fasting). Plasma glucose was monitored before (b) and after (a) RQ experiment. Other plasma parameters were measured only after RQ experiment. Data are means ± SE, n = 5-8. *p < 0.05, **p < 0.01, or ***p < 0.001 versus Ad-GFP; and ‡ p < 0.05, ‡ ‡ p < 0.01, or ‡ ‡ ‡ p < 0.001 versus Ad-GK.
Elevation of whole-body energy expenditure expenditure were greater than Ad-Bif-BPD treatment. In contrast, the pair-fed mice (Ad-GFP-PF) showed similar energy exTo test whether enhancing hepatic glycolysis leads to an increase in whole-body energy expenditure, the respiratory quopenditure compared to Ad-GFP-treated mice, indicating that restriction of food intake does not affect whole-body fatty acid tient (RQ) of virus-treated mice was measured on day 7. Ad-GK and Ad-Bif-BPD treatments caused identical reductions of oxidation. There were no differences in the motion index of any treated mice, indicating that physical activities of all groups of RQ values compared to mice treated with control virus, Ad-GFP ( Figure 3A ). Food restriction did not change RQ values in treated mice were similar (data not shown). We next measured palmitate oxidation rates of the liver and the pair-fed mice. It should be noted that RQ values were lower in both Ad-GK-and Ad-Bif-BPD-treated mice than in Ad-GFPskeletal muscle to determine the contribution of individual tissues to the elevated whole-body fatty acid oxidation. Treatment treated mice at the initial time points. Moreover, RQ values were further reduced late in the 4 hr measurement when the mice with either Ad-GK or Ad-Bif-BPD caused a dramatic increase in the rates of palmitate oxidation in skeletal muscle (Figure were becoming fasted, compared to Ad-GFP-treated mice.
Energy expenditure, calculated from RQ data (Baar et al., 3C) . In contrast, both treatments slightly decreased the rates of palmitate oxidation in liver. These data suggested that extra-2004; Chen and Heiman, 2001), was elevated in both Ad-GKand Ad-Bif-BPD-treated mice compared to Ad-GFP-treated hepatic tissues, including skeletal muscle, made a dominant contribution to an increase in whole-body fatty acid oxidation. mice ( Figure 3B ). The effects of Ad-GK treatment on energy Obese KK/H1J mice were treated with adenovirus (Ad-GFP, Ad-GK, or Ad-Bif-BPD) on day 0 and followed for 7 days. A group of mice (Ad-GFP-PF) was treated with Ad-GFP and pair fed with Ad-Bif-BPD-treated mice. Data are means ± SE, n = 5-8. *p < 0.05, **p < 0.01, or ***p < 0.001versus Ad-GFP; † p < 0.05 or † † p < 0.01 versus Ad-GFP-PF; and ‡ p < 0.05 versus Ad-GK. A) RQ was measured on day 7 using indirect calorimetry. B) Energy expenditure was calculated from RQ data. C) Changes in the rates of palmitate oxidation. Results were expressed as the percentage of liver or muscle control.
Reduction of plasma levels of glucose and insulin
differently. Because food intake is controlled by the CNS through integration of hormonal and nutritional signals (Flier, Enhancing hepatic glycolysis caused a suppression of HGP. This effect was thought to be responsible for lowering plasma 2004; Havel, 2001) , we next measured changes in mRNA levels of neuropeptides that control feeding behavior. Upon Ad-Bifglucose levels, which were observed with either Ad-GK or AdBif-BPD treatment (Table 1) . Due to these lower levels, glu-BPD treatment, the mRNA levels of hypothalamic NPY were decreased, suggesting that the CNS is secondarily affected. cose-stimulated insulin release (GSIR) is decreased in the pancreatic β cells, resulting in a subsequent reduction of plasma However, Ad-GK treatment did not affect NPY mRNA levels ( Figure 4B ). levels of insulin. Moreover, reductions of plasma levels of glucose and insulin were identical in the two liver-targeted manipInsulin may cooperate with leptin in the CNS signaling pathway for regulation of food intake (Flier, 2004; Havel, 2001 ; Spieulations. Initially, we used the decrease in plasma glucose and subsequent decrease in insulin levels as a simple explanation gelman and Flier, 2001). Because plasma insulin levels were decreased similarly in both Ad-GK-and Ad-Bif-BPD-treated for the observed effects on promoting fatty acid oxidation in extrahepatic tissues. However, the dramatic differences in many mice, we measured levels of plasma leptin. In the Ad-GFPtreated obese mice, plasma leptin levels were high. Upon Adaspects produced by the treatments strongly indicate that reducing obesity by enhancing hepatic glycolysis is a compliBif-BPD treatment, plasma leptin levels were moderately decreased (Table 1) . Ad-GK treatment, surprisingly, produced a cated process involving additional mechanisms. dramatic decrease in leptin levels. This decrease, however, was not accompanied by a change in food intake.
Differential effects on food intake
Food intake is one of two determinants of energy balance. We monitored food intake of virus-treated mice daily. Ad-Bif-BPD Differential effects on lipid metabolism Although Ad-GK or Ad-Bif-BPD treatment produced identical treatment caused a suppression of food intake compared to Ad-GFP treatment, whereas Ad-GK treatment did not (Figure effects on lowering plasma glucose and insulin levels, the two treatments caused strikingly different profiles of lipid metabo-4A). Thus, enhancing hepatic glycolysis at the step from glucose to G6P or from F6P to F16P 2 affects feeding behavior lism. Upon Ad-GK treatment, the liver showed a 2-to 3-fold Obese KK/H1J mice were treated with adenovirus (Ad-GFP, Ad-GK, or Ad-Bif-BPD) on day 0 and followed for 7 days. Data are means ± SE. *p < 0.05 or **p < 0.01 versus Ad-GFP and ‡ p < 0.05 or ‡ ‡ p < 0.01 versus Ad-GK. A) Cumulative food intake (n = 5-8). A group of mice (Ad-GFP-PF) was treated with Ad-GFP and pair fed with Ad-Bif-BPD-treated mice. The line indicating changes in food intake of Ad-GFP-PF-treated mice was superimposable on that of Ad-Bif-BPD-treated mice due to pair feeding. B) Changes in mRNA levels of hypothalamic AgRP, NPY, CART, and POMC (n = 3). The mRNA levels were determined by real-time PCR.
increase in the size and a distinct pale-to-white color that was dramatically decreased in the liver of Ad-GK-treated mice and was not significantly changed in the liver of Ad-Bif-BPDdifferent from that of mice in all other groups ( Figure 5A ). These changes were consistent with 4-fold increases in hepatic tritreated mice ( Figure 5E ). The decreased phosphorylation of ChREBP was likely associated with an elevation of hepatic glycerides (TG, Table 1 ). Ad-Bif-BPD treatment, in contrast, did not change the weight or appearance of liver and did not influlevels of xylulose-5-phosphate (Xu5P), a regulatory metabolite (see below). ence hepatic TG levels. In addition, Ad-GK treatment exacerbated the existing hyperlipidemia in the KK/H1J mice, eleSince AMP-activated protein kinase (AMPK) plays an important role in regulation of lipid synthesis in the liver, we also vating plasma levels of triglycerides (TG) by 3-fold, whereas Ad-Bif-BPD treatment decreased plasma TG levels (Table measured changes in protein amount and phosphorylation state of AMPK. In the liver of Ad-GK-treated mice, protein 1). To test whether hepatic lipogenesis was responsible for changes in the lipid profile, we measured the in vivo rates of amount and phosphorylation of AMPK were dramatically decreased ( Figure 5E ). These decreases were not observed with lipogenesis in liver. As expected, Ad-GK treatment caused a significant increase in hepatic lipogenesis. However, Ad-BifAd-Bif-BPD treatment. Instead, AMPK phosphorylation was increased. Clearly, enhancing hepatic glycolysis at two distinct BPD treatment caused a decrease in hepatic lipogenesis (Figure 5B) . Similar effects were also observed in rat primary hepasteps resulted in opposite effects on AMPK expression and phosphorylation. tocytes ( Figure 5B ), indicating that the outcome of elevating glycolysis on lipogenesis is dramatically different depending on which step of glycolysis is targeted.
Differential effects on hepatic G6P and Xu5P levels Hepatic levels of G6P and Xu5P are closely associated with To understand the underlying mechanism, we measured changes in mRNA levels of lipogenic enzymes, acetyl CoA carlipid metabolism in the liver (Kabashima et al., 2003; Towle et al., 1997) . Thus, we measured changes in their levels (Table 1) . boxylase 1 (ACC1), and fatty acid synthase (FAS). In the liver, ACC1 and FAS mRNA levels were increased in Ad-GK-treated With Ad-GK treatment, the hepatic levels of both G6P and mice, whereas they were decreased in Ad-Bif-BPD-treated Xu5P were increased (0.93 ± 0.03 mol/g and 87.29 ± 10.43 mice ( Figure 5C ). Similar effects have been observed in Adnmol/g, respectively) compared to those of mice treated with GK-or Ad-Bif-BPD-treated normal 129J mice (J.E.K., C.W., Ad-GFP (0.65 ± 0.19 mol/g and 57.13 ± 7.45 nmol/g, respec-C.J.H., B. Clem, and A.J.L., unpublished data). Unlike changes tively). The increases in G6P were consistent with the effects in the liver, ACC1 and FAS mRNA levels were decreased in of GK on phosphorylation of glucose, while the increases in skeletal muscle upon Ad-GK or Ad-Bif-BPD treatment (Fig- Xu5P were likely associated with increased flux through penure 5D Livers from Ad-Bif-BPD-, Ad-GFP-, or Ad-GK-treated mice (from left to right) were collected on day 7. The dark bar is at a length of 1 cm. In (B), (C), and (D), data are means ± SE. *p < 0.05, **p < 0.01, or ***p < 0.001 versus Ad-GFP, and ‡ ‡ ‡ p < 0.001 versus Ad-GK. B) Changes in lipogenesis. Top, in vivo lipogenesis in the liver (n = 3-4); bottom, lipogenesis in rat primary hepatocytes (measured from three to four independent experiments). C) Changes in mRNA levels of ACC1 and FAS in the liver (n = 5-8). D) Changes in mRNA levels of ACC1 and FAS in skeletal muscle (n = 5-8). E) Changes in protein amount and phosphorylation of ChREBP and AMPK in the liver. ⌬ Phospho-ChREBP was analyzed from immunoprecipitation complex using phospho-protein gel stain.
2002). Because insulin, along with glucose, controls peripheral glycolysis was increased similarly in the liver, as indicated by elevated hepatic lactate levels. In addition, the rates of in vivo fatty acid oxidation and plasma levels of glucose, and because insulin can be manipulated secondarily via modulation of HGP, glycolysis were also increased similarly. These effects led to a similar decrease in HGP, which resulted in a similar reduction we used adenoviral overexpression of GK or a mutated form of 6PFK2/FBP2 to test whether and how enhancing hepatic of levels of plasma glucose and, secondarily, a similar reduction of levels of plasma insulin. As a result, there was a relief glycolysis reduces obesity. Using these two manipulations, we were able to enhance glycolysis predominantly in the liver. Sigof the inhibition of hyperinsulinemia on lipolysis in adipose tissue and fatty acid oxidation in muscle (Chien et al., 2000; Rasnificantly, both of these manipulations resulted in identical glucose and insulin lowering effects. Because of this, we were mussen et al., 2002; Sidossis and Wolfe, 1996; Stumvoll et al., 2000) . In addition, when HGP was decreased, whole-body gluable to dissect hepatic glycolysis at different steps and explore the role of each in the regulation of whole-body energy balcose disposal was also reduced, indicating a decrease in glucose utilization in peripheral tissues, i.e., muscle. From this ance. These novel studies highlight both the central role of the liver in systemic energy balance and the mechanisms for difperspective, an increase in fat utilization in muscle was expected to compensate for a reduction of glucose as a fuel. ferential regulation of hepatic lipogenesis.
Upon hepatic overexpression of either GK or 6PFK2/FBP2, This change was reflected by decreases in the RQ values. As expected, visceral fat content was decreased and the rates of liver to the brain, functioning as an additional component of the brain-liver circuit as proposed by Rossetti and colleagues fatty acid oxidation in skeletal muscle were increased in the treated mice, which contributed to the elevation of energy ex- (Pocai et al., 2005) . It should be pointed out that we can not completely rule out the possibility that there may be a small penditure. Since the observed effects were nearly identical with GK or 6PFK2/FBP2 overexpression, the underlying mechaamount of infection of the CNS by adenovirus treatment. Even if this is the case, it is likely that GK and 6PFK2/FBP2 overexnism(s) is likely the same. Therefore, reducing hyperinsulinemia secondary to lowering hyperglycemia by enhancing hepatic pression generate different central signals for regulation of feeding. glycolysis may be the main contributor to an elevation of energy expenditure. This mechanism suggests that lowering Given the fact that GK or 6PFK2/FBP2 overexpression caused similar changes in rates of glycolysis but different conplasma glucose levels likely mediates the liver-initiated intertissue interaction with extrahepatic tissues, such as pancreatic β sequences on the lipid profile and reduction of obesity, it is clear that the site at which glycolysis is enhanced in the liver cells, adipose, and skeletal muscle.
When energy expenditure was similarly elevated, a similar can influence the outcome of whole-body lipid metabolism, as well as whole-body energy balance. This is particularly true reduction of obesity was also expected. However, this was not the case. 6PFK2/FBP2 overexpression caused a more prowith regard to the correlation between plasma TG levels and hypothalamic NPY mRNA levels. Since plasma TG levels were nounced effect on reduction of body weight than did GK overexpression. This difference was attributable to differential efclosely associated with hepatic lipogenesis, how lipogenesis was regulated in the liver was the key. Here, the opposite effects of the two treatments on food intake. 6PFK2/FBP2 overexpression led to a suppression of food intake that was fects on ACC1 and FAS mRNAs contributed to differential regulation of hepatic lipogenesis. In light of the fact that gene exnot observed with GK overexpression. When energy expenditure is elevated, food intake is usually increased due to pression of ACC1 and FAS is regulated by ChREBP and dephosphorylation of ChREBP is controlled by Xu5P-activated counterregulation, which contributes to decreased effectiveness in reduction of obesity (Jequier, 2002; Perseghin, PP2A (Kabashima et al., 2003) , a model for the underlying mechanism(s) was proposed. In this model, GK overexpression 2001). In this regard, enhancing hepatic glycolysis at the step from F6P to F16P 2 promoted cooperative regulation of energy caused an increase in Xu5P levels through the pentose phosphate pathway. This increase activated PP2A, which led to an balance to reduce obesity. Since food intake is controlled by the CNS (Flier, 2004; Havel, 2001) , it is likely that 6PFK2/FBP2 activation of ChREBP by removal of inhibitory phosphate(s). As a result, expression of ACC1 and FAS was increased. In addioverexpression led to secondary effects on the CNS. This view was supported by a decrease in hypothalamic NPY mRNA tion, NADPH, another key product of the pentose phosphate pathway required for lipogenesis, was also likely increased to levels. With adenoviral overexpression, the initial alterations occurred in the liver (Becard et al., 2001; O'Doherty et al., promote lipogenesis. None of these changes occurred upon 6PFK2/FBP2 overexpression. Instead, levels of G6P, Xu5P, and 1999). Thus, liver-derived signals, neuronal, hormonal, or metabolic, might contribute to observed effects on food intake or ChREBP phosphorylation were changed in a pattern favoring a decrease in lipogenesis, consistent with the proposed model. hypothalamic NPY mRNA levels. In addition, the generation of liver-derived signals was likely determined by how hepatic gly-AMPK also controls lipid synthesis in the liver. Activation of AMPK by phosphorylation inhibits ACC1 (Kahn et al., 2005) . colysis is enhanced. In the liver, AMPK, a key cellular energy sensor (Kahn et al., 2005) , showed increased phosphorylation In addition, phosphorylation of AMPK inhibits the binding of ChREBP to DNA, which is required for induction of expression upon 6PFK2/FBP2 overexpression. Thus, it might serve as one of the signals to trigger an unknown hepatic neuronal sensor of genes for lipogenic enzymes . Upon enhancing glycolysis via GK overexpression, hepatic AMPK (or sensors) that is (are) connected with the CNS. Alternatively, 6PFK2/FBP2 overexpression might generate liver-derived sigwas dramatically decreased in both protein amount and phosphorylation. These changes are expected to cause a decrease nals, i.e., unknown protein(s), which would be secreted into the bloodstream and affect the CNS. in inhibition of ACC1 and an increase in the binding of ChREBP to DNA. As a result, lipid synthesis would be favored in the TG and leptin similarly may serve as circulating signals that impact the CNS. In fact, plasma TG levels correlated positively liver, which is what was observed. Upon enhancing hepatic glycolysis via 6PFK2/FBP2 overexpression, the increased with NPY mRNA levels in all virus-treated mice. Leptin levels did not but the ratios of leptin to insulin did correlate negatively phosphorylation of hepatic AMPK and decreased mRNAs of ACC1 and FAS were consistent with the AMPK-related mechawith NPY mRNA levels (data not shown). These correlations were consistent with the observed effects on food intake. In nisms for a repression of lipid synthesis. How these opposite effects on hepatic AMPK were produced was not clear. addition, leptin may cooperate with insulin on affecting the CNS. Since insulin stimulates leptin gene expression (Havel, In conclusion, the liver plays an important role in the regulation of energy balance, and this is demonstrated by the reduc-2001), a reduction of plasma insulin levels was expected to cause a decrease in plasma levels of leptin. This decrease was tion of obesity brought about by enhancing hepatic glycolysis. In addition, how hepatic glycolysis is enhanced determines the observed with either GK or 6PFK2/FBP2 overexpression. However, the two treatments also caused dramatic differences in overall outcome of whole-body energy balance, evidenced by the fact that GK or 6PFK2/FBP2 overexpression caused difleptin levels even though insulin levels were the same. These differences suggested that an additional factor (or factors) is ferential effects on reduction of body weight and changes of lipid profiles in obese mice. When hepatic glycolysis is eninvolved in the regulation of leptin expression. Regardless of the mechanism (or mechanisms) for reduction of food intake, hanced at the downstream step, energy balance is cooperatively regulated via the intertissue interactions between the liver decreases in hypothalamic NPY mRNA levels serve as evidence of the existence of intertissue communication from the and extrahepatic tissues. Through suppression of HGP, en- Enhancing hepatic glycolysis via GK or 6PFK2/ FBP2 overexpression causes an elevation of energy expenditure, likely through effects secondary to lowering plasma insulin and glucose levels. However, the two modulations cause opposite consequences on lipid profiles as well as differences in food intake. On the right side, when hepatic glycolysis is enhanced at the step from glucose to glucose-6-phosphate, hepatic lipogenesis is increased. On the left side, when hepatic glycolysis is enhanced at the step from fructose-6-phosphate to fructose-1,6-bisphosphate, food intake is suppressed and hepatic lipogenesis is decreased. Thus, when glycolysis is enhanced at the downstream step, the liver plays an important role in cooperative regulation of energy balance to reduce obesity.
of mice comprised of those treated with Ad-GFP, Ad-GK, Ad-Bif-BPD, and hancing hepatic glycolysis at the step from F6P to F16P 2 leads Ad-GPF-PF (n = 5-8) were used for RQ measurements. After RQ experito a decrease in plasma insulin levels secondary to a reduction ments, blood samples were collected from the tail vein, and mice were of plasma glucose levels, which in turn promotes fatty acid immediately sacrificed via cervical dislocation. The abdomen was quickly oxidation in extrahepatic tissues, i.e., skeletal muscle, and eleopened. Epididymal, perinephric, and mesenteric fat depots were dissected vates whole-body energy expenditure. In addition, unknown and weighed as visceral fat content (Barzilai et al., 1999) . After weighing, the liver and skeletal muscle were rapidly trimmed and divided into two liver-derived signal (or signals) is likely generated uniquely in parts. One part of each tissue was frozen in liquid nitrogen and subseresponse to enhancing hepatic glycolysis at the downstream quently stored at −70°C for further analyses. The second part of the liver step and secondarily affects the hypothalamus, contributing to or skeletal muscle sample was immediately cooled in ice-cold buffer and a suppression of food intake. The mechanistic scheme is sumhomogenized. Tissue homogenates were used for determination of fatty marized in Figure 6 , showing how GK and 6PFK2/FBP2 overacid oxidation as described below. The hypothalamic regions were disexpression regulates energy balance differently.
sected from 1 mm thick sagittal sections of fresh brain (Minokoshi et al., 2004) . The arcuate nucleus (ARC), paraventricular (PVN), ventromedial Experimental procedures (VMH), and dorsomedial (DMH) were collected microscopically, rapidly trimmed and frozen in liquid nitrogen, and subsequently stored at −70°C Adenovirus preparation for further analyses. Two additional sets of mice treated with Ad-GFP, AdAdenoviruses encoding green fluorescent protein (Ad-GFP), glucokinase GK, and Ad-Bif-BPD (n = 4-6) were used separately for euglycemic/hyperin-(Ad-GK), and bisphosphatase-deficient 6PFK2/FBP2 (Ad-Bif-BPD) were sulinemic studies and measurement of in vivo lipogenesis. All study protoprepared as previously described (O'Doherty et al., 1999; , cols were reviewed and approved by the Institutional Animal Care and Use 2004). The expressed bisphosphatase-deficient 6PFK2/FBP2, possessing
Committees of the University of Minnesota. a serine-32 to alanine mutation and a histidine-258 to alanine mutation, was designed to generate a higher level of F26P 2 compared to wild-type Primary hepatocyte preparation and treatment enzyme.
Primary hepatocytes were isolated from SD rats as previously described (Stoeckman and Towle, 2002) . Hepatocytes were plated into 12-well plates Animal treatments (w7 × 10 5 cells/well) for 4 hr with Williams E media. After overnight incubaMale obese KK/H1J mice were 12-14 weeks old (w35 g) and obtained from tion, cells were treated with Ad-GFP, Ad-GK, or Ad-Bif-BPD (3.5 × 10 7 pfu/ the Jackson Laboratory (Bar Harbor, Maine). All mice were fed ad libitum well) for 2 hr in Williams E media without FBS or insulin. Cells were then and individually housed and maintained on a 12:12 hr light-dark cycle, with washed with PBS and incubated in Williams E media without FBS or insulights turned on at 06:00. Adenovirus (Ad-GFP, Ad-GK, or Ad-Bif-BPD) was lin overnight. administered at 17:00 of day 0 via tail vein at a dose of w5 × 10 11 pfu/ml × 0.45 ml. Body and food weight were measured daily at 10:00 on day −2 RQ measurement through day 7. The pair-fed mice (treated with Ad-GFP) were provided with Respiratory gas measurements were taken by indirect calorimetry using a the same amount of food as voluntarily ingested the previous day by Adcomputer-controlled, open circuit system (Applied Electrochemistry Inc, Pittsburgh, Pennsylvania). Measurements were made at 10:00 on day 7. Bif-BPD-treated mice at 17:00 on day −2 through day 7. At day 7, one set After 1 hr to acclimate to the chamber, gases were sampled from the chamAcknowledgments ber every 2 min for the remaining 4 hr. During the entire 5 hr RQ measurement, food was restricted. The system then calculated the volumes of O 2 This work is supported by a P&F Program Award from the Minnesota Obesity Center that is funded by an NIH 3P30-DK50456-08 grant, a Research consumed (VO 2 , ml/kg body weight) and CO 2 produced (VCO 2 , ml/kg body weight) by the mouse every 2 min (Baar et al., 2004; Chen and Heiman, Award 3487-9227- (Muse et al., 2004; Rossetti and Giaccari, 1990; Rossetti et al., 1997) . 
